Skip to Content

KAMILLOSAN CHAMOMILE OINTMENT

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Nipasept (containing E214, E216 and E218) which may cause allergic



Cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis)

Read all of this leaflet carefully, because it contains
important information for you.

Kamillosan Ointment also contains maize oil, wool fat (lanolin), yellow soft paraffin,
yellow beeswax, emulsifying wax (containing cetostearyl alcohol and sodium
laurilsulfate) and Nipasept (Methyl parahydroxybenzoate E218, Ethyl
parahydroxybenzoate E214 and Propyl parahydroxybenzoate E216).

Product license holder Omega Pharma Ltd., 1st Floor, 32 Vauxhall Bridge
Road, London, SW1V 2SA, United Kingdom.
Product Authorisation holder Chefaro Ireland Limited, First Floor, Block A,
The Crescent Building, Northwood Office Park, Dublin 9, Ireland.

This leaflet was last updated November 2012

KAM01771112v1

PL 02855/0035

PA 1186/7/1

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide